| 11833215 |
CKIT antibody drug conjugates |
Steven Bruce Cohen, Dylan L. Daniel, Catrin Finner, Bernhard Hubert Geierstanger, Thomas Huber +5 more |
2023-12-05 |
$40,556,000 |
| 11179365 |
Pharmaceutical combination comprising LSZ102 and ribociclib |
Larry Alexander Gaither |
2021-11-23 |
$11,822,000 |
| 10786578 |
CKIT antibody drug conjugates |
Steven Bruce Cohen, Dylan L. Daniel, Catrin Finner, Bernhard Hubert Geierstanger, Thomas Huber +5 more |
2020-09-29 |
$23,191,000 |
| 10695333 |
Pharmaceutical combination comprising LSZ102 and alpelisib |
Larry Alexander Gaither |
2020-06-30 |
$115,788,000 |
| 10626172 |
Antibody drug conjugates |
Steven Bruce Cohen, Jason Damiano, Clemens Dürr, Thomas Huber, Daniel Menezes +3 more |
2020-04-21 |
$111,360,000 |
| 10117953 |
Antibody drug conjugates |
Steven Bruce Cohen, Christie P. Fanton, Thomas Huber, Kathy Miller, Siew Ho Schleyer +2 more |
2018-11-06 |
$36,513,000 |
| 10005836 |
Antibody drug conjugates |
Steven Bruce Cohen, Jason Damiano, Clemens Dürr, Thomas Huber, Daniel Menezes +3 more |
2018-06-26 |
$8,231,000 |
| 9789203 |
cKIT antibody drug conjugates |
Steven Bruce Cohen, Christie P. Fanton, Catrin Finner, Thomas Huber, Kathy Miller +2 more |
2017-10-17 |
$26,312,000 |
| 9498543 |
Antibody drug conjugates |
Steven Bruce Cohen, Christie P. Fanton, Thomas Huber, Kathy Miller, Siew Ho Schleyer +2 more |
2016-11-22 |
$6,238,000 |
| 8735599 |
Substituted imidazole derivates |
Weibo Wang, Paul A. Barsanti, Xia Yia, Rustum Boyce, Sabina Pecchi +21 more |
2014-05-27 |
$14,038,000 |
| 8664256 |
Kinesin inhibitors as cancer therapeutics |
Paul A. Barsanti, David Duhl, Michel Faure, Paul A. Renhowe, Annette Walter |
2014-03-04 |
$10,243,000 |
| 8546434 |
Triazole compounds as KSP inhibitors |
Paul A. Barsanti, Yu Ding, David Duhl, Wooseok Han, Cheng Hu +1 more |
2013-10-01 |
$9,976,000 |
| 8318791 |
Substituted imidazole derivatives |
Weibo Wang, Paul A. Barsanti, Yia Xia, Rustum Boyce, Sabina Pecchi +21 more |
2012-11-27 |
$9,551,000 |
| 8252832 |
Kinesin inhibitors as cancer therapeutics |
Paul A. Barsanti, David Duhl, Michel Faure, Paul A. Renhowe, Annette Walter |
2012-08-28 |
$7,435,000 |
| 7626040 |
Substituted imidazole compounds as KSP inhibitors |
Paul A. Barsanti, Yi Xia, Weibo Wang, Kris Mendenhall, Liana Lagniton +9 more |
2009-12-01 |
$20,169,000 |
| 7576221 |
Substituted imidazole derivatives |
Weibo Wang, Paul A. Barsanti, Yia Xia, Rustum Boyce, Sabina Pecchi +21 more |
2009-08-18 |
$39,170,000 |
